Samarium-153 DOTMP

N/A

Report date: 2025/11/28 15:16:12
NME

Base Information

Drug NameSamarium-153 DOTMP
Drug Alias NameCycloSam153-Sm-DOTMPSm-153-DOTMPTLX090-Tx153Sm-DOTMP +[6] 
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Samarium > 153SmRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionIonising radiation emitters
TargetsUpdating
Therapy Area/IndicationsBone metastasesSolid tumoursBone Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIsoTherapeutics Group LLC
China Registration ClassN/A

Develop Information

Active CompaniesTelix Pharmaceuticals (Innovations) Pty LtdQsam Therapeutics IncTelix Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsBone metastasesSolid tumoursBone Diseases +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A